Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Expression of huCdc7 in colorectal cancer.

Chen HJ, Zhu Z, Wang XL, Feng QL, Wu Q, Xu ZP, Wu J, Yu XF, Qian HL, Lu Q.

World J Gastroenterol. 2013 May 28;19(20):3130-3. doi: 10.3748/wjg.v19.i20.3130.

2.

Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.

Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.

J Clin Gastroenterol. 2009 Oct;43(9):831-7. doi: 10.1097/MCG.0b013e31819cc731.

PMID:
19461527
3.

Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.

Al Obeed OA, Alkhayal KA, Al Sheikh A, Zubaidi AM, Vaali-Mohammed MA, Boushey R, Mckerrow JH, Abdulla MH.

World J Gastroenterol. 2014 Dec 28;20(48):18390-6. doi: 10.3748/wjg.v20.i48.18390.

4.

Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.

Kanaji S, Saito H, Tsujitani S, Matsumoto S, Tatebe S, Kondo A, Ozaki M, Ito H, Ikeguchi M.

Oncology. 2006;70(2):126-33.

PMID:
16645325
5.

Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.

Luo B, Yun X, Fan R, Lin YD, He SJ, Zhang QM, Mo FR, Chen F, Xiao SW, Xie XX.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2835-45.

6.

A novel molecular marker of prognosis in colorectal cancer: Vasohibin-1.

Yan Y, Shen Z, Ye Y, Jiang K, Zhang H, Shen C, Mustonen H, Puolakkainen P, Wang S.

Med Oncol. 2014 Feb;31(2):816. doi: 10.1007/s12032-013-0816-0.

PMID:
24366689
7.

Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.

Zhou T, Zhang G, Liu Z, Xia S, Tian H.

Int J Colorectal Dis. 2013 Jan;28(1):19-24. doi: 10.1007/s00384-012-1528-1.

PMID:
22772712
8.

Tissue and serum galectin-1 expression in patients with colorectal carcinoma.

Sheng TH, Rong LX, Li ZY, Bo J, Lei S.

Hepatogastroenterology. 2012 Mar-Apr;59(114):389-94. doi: 10.5754/hge09232.

PMID:
22353504
9.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

10.

The expression of the phosphatase regenerating liver 3 gene is associated with outcome in patients with colorectal cancer.

Tamagawa H, Oshima T, Yoshihara K, Watanabe T, Numata M, Yamamoto N, Tuschida K, Shiozawa M, Morinaga S, Akaike M, Masuda M, lmada T.

Hepatogastroenterology. 2012 Oct;59(119):2122-6.

PMID:
22440248
11.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131.

PMID:
19535783
12.

Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.

Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, Nabeshima K, Iwasaki H, Kuroki M.

Anticancer Res. 2007 Nov-Dec;27(6A):3729-34.

13.

Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.

Likui W, Hong W, Shuwen Z.

J Gastrointest Surg. 2010 Jan;14(1):74-81. doi: 10.1007/s11605-009-1035-z.

PMID:
19763701
14.

Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.

Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW, Wang ML, Hu WG, Liu BY, Zhu ZG.

J Gastroenterol Hepatol. 2006 Oct;21(10):1596-603.

PMID:
16928223
15.

Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin.

Xing X, Lai M, Gartner W, Xu E, Huang Q, Li H, Chen G.

Proteomics. 2006 May;6(9):2916-23.

PMID:
16586428
16.

Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer.

Deves C, Renck D, Garicochea B, da Silva VD, Giulianni Lopes T, Fillman H, Fillman L, Lunardini S, Basso LA, Santos DS, Batista EL Jr.

Virchows Arch. 2011 Apr;458(4):421-30. doi: 10.1007/s00428-011-1053-6.

PMID:
21318373
17.

Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival.

Ye C, Cai Q, Dai Q, Shu XO, Shin A, Gao YT, Zheng W.

Cancer. 2007 May 1;109(9):1729-35.

18.

The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.

Zhang MS, Hu AH, Qiu H, Xiong HH, Chen Y.

Med Oncol. 2012 Jun;29(2):928-32. doi: 10.1007/s12032-011-9881-4.

PMID:
21380782
19.

The roles of JK-1 (FAM134B) expressions in colorectal cancer.

Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK.

Exp Cell Res. 2014 Aug 1;326(1):166-73. doi: 10.1016/j.yexcr.2014.06.013.

PMID:
24973512
20.

Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Miyoshi N, Ishii H, Mimori K, Takatsuno Y, Kim H, Hirose H, Sekimoto M, Doki Y, Mori M.

Br J Cancer. 2009 Nov 17;101(10):1664-70. doi: 10.1038/sj.bjc.6605361.

Supplemental Content

Support Center